Obesity And Health

Why does belly fat rise after 30 even when diet and workouts stay same?

Why does belly fat creep up after 30 even if nothing has changed? A California-based gastroenterologist trained at AIIMS explains the science behind it and what can help reverse it

From fibremaxxing to GLP-1s: What were India's top health trends in 2025?

From fibremaxxing and longevity clinics to GLP-1 drugs, AI hospitals and workplace mental health, 2025 reshaped how India talks about prevention, ageing and wellbeing

WHO calls for 'responsible use' of GLP-1 drugs for long term obesity care

The guideline reframes obesity as a chronic disease needing lifelong care, recommending GLP-1 therapies with behavioural support rather than relying on medication alone

Good old kalonji may help control fat and cholesterol, says new study

A new clinical trial shows that kalonji, long used in Indian kitchens, may help lower cholesterol and slow fat formation, offering a natural metabolic boost alongside regular diet and lifestyle habits

Nearly 70% of Americans may be obese under new norms, study warns

Researchers warn that the findings reflect a growing global health crisis, as outdated BMI standards fail to capture hidden fat-linked risks contributing to chronic disease.

Liver fat, not bodyweight, predicts health risks in obese children: Study

Children with "unhealthy obesity" were three times more likely born from high-risk pregnancies, linking early-life factors to later metabolic health risks

Obesity now affects 1 in 10 children, Unicef warns of global crisis

Ultra-processed foods, aggressive marketing and weak regulations are driving obesity among children. Unicef urges governments to act now to protect children's health and future potential

Undiagnosed diabetes poses major global health risk, warns new study

A global study reveals that millions go undiagnosed with diabetes. Researchers call for better education, early screening, and affordable treatment access

Anti-obesity drug war heats up as Wegovy and Mounjaro boost sales

India's Rs 628-crore anti-obesity market sees heightened competition as Wegovy and Mounjaro post strong sales amid rising obesity and growing doctor awareness

Can Mounjaro transform obesity care? ₹50 crore sales in three months

Eli Lilly's Mounjaro has seen explosive growth since its March launch in India, with sales soaring to Rs 50 crore in three months

Novo Nordisk launches Wegovy in India to tackle obesity and heart risk

Wegovy is India's first weekly injectable approved for both long-term weight loss and reducing heart risks in obese and overweight adults

Chubby isn't cute: Belly fat in kids linked to heart risk by age 10

Belly fat growth patterns in childhood are tied to insulin resistance, high blood pressure, and early heart disease risk by age 10, finds a decade-long Danish study presented at ECO 2025

Obesity cure is here? Why it could be a win-win for all stakeholders

We Indians have had a different perspective around obesity

Statsguru: Obesity, a pandemic in the making, may hit India hard by 2050

The number of Indian obese adults increased from 5.76 million in 1991 to 46.78 million in 2021; it is poised to reach 173.73 million by 2050

Small cities, healthier appetite: Tier-III cities lead healthy food growth

According to Unicommerce, order volumes for healthy food staples and snacks surged by 60 per cent year-on-year

No suicidal thoughts link to diabetes, obesity drugs, finds UK regulator

The Medicines and Healthcare products Regulatory Agency (MHRA) began a review of safety data for the class of drugs, known as GLP-1 receptor agonists, more than a year ago

Waist-to-height ratio more effective than BMI for obesity diagnosis: Study

Obesity can no longer be just defined by body mass index (BMI) and rather should be about how body fat is distributed throughout one's body, researchers said while launching a new framework for diagnosing and managing obesity. Published in the journal Nature Medicine, the framework looks specifically at fat accumulated in the abdomen, measured as 'waist-to-height ratio' -- an increased value of which is related to a higher risk of developing cardiometabolic complications, according to the researchers. An "important novelty" of the framework is including a waist-to-height ratio higher than 0.5, along with a BMI of 25-30, for diagnosing obesity, the authors, representing the European Association for the Study of Obesity (EASO), said. "The choice of introducing waist-to-height ratio, instead of waist circumference, in the diagnostic process is due to its superiority as a cardiometabolic disease risk marker," they wrote. Accumulation of abdominal fat is a more reliable predictor of hea

New oral diabetes and obesity drug sale doubles in India amid demand surge

The sales of Novo Nordisk's Rybelsus tablet, used for diabetes treatment and weight reduction, more than doubled to Rs 363 crore this year from Rs 147 crore last year

Biocon leads India's push into anti-obesity drugs as patents lapse

The company, helmed by Kiran Mazumdar Shaw, is leading the charge among Indian drugmakers - the world's largest supplier of generic medicines - as they race to grab a slice of the obesity drugs market

Obesity drugs will not solve our billion-person problem, warns WHO

New obesity drugs such as Novo Nordisk A/S's Wegovy and Eli Lilly & Co.'s Zepbound could be an $80 billion market by 2030